tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Outlook for Roivant Sciences: Buy Rating Backed by Brepo’s Potential and Financial Opportunities
PremiumRatingsOptimistic Outlook for Roivant Sciences: Buy Rating Backed by Brepo’s Potential and Financial Opportunities
1M ago
Optimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
Premium
Ratings
Optimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
2M ago
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
Premium
Ratings
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
2M ago
Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
PremiumRatingsStrategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
2M ago
Roivant Sciences Reports Progress and Financial Results
Premium
Company Announcements
Roivant Sciences Reports Progress and Financial Results
2M ago
Roivant Sciences Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Roivant Sciences Earnings Call: Balancing Growth and Challenges
2M ago
Strategic Advancements and Growth Potential Justify Buy Rating for Roivant Sciences
PremiumRatingsStrategic Advancements and Growth Potential Justify Buy Rating for Roivant Sciences
4M ago
Roivant Sciences Announces Leadership Changes at Immunovant
Premium
Company Announcements
Roivant Sciences Announces Leadership Changes at Immunovant
4M ago
Immunovant appoints Eric Venker as CEO, Girao as CFO
Premium
The Fly
Immunovant appoints Eric Venker as CEO, Girao as CFO
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100